SI1651596T1 - Novi derivati ditiobis aminobutan sulfonatov in sestavki ki jih vsebujejo - Google Patents

Novi derivati ditiobis aminobutan sulfonatov in sestavki ki jih vsebujejo

Info

Publication number
SI1651596T1
SI1651596T1 SI200431385T SI200431385T SI1651596T1 SI 1651596 T1 SI1651596 T1 SI 1651596T1 SI 200431385 T SI200431385 T SI 200431385T SI 200431385 T SI200431385 T SI 200431385T SI 1651596 T1 SI1651596 T1 SI 1651596T1
Authority
SI
Slovenia
Prior art keywords
aminobutane
dithiobis
sulfonates
compositions
same
Prior art date
Application number
SI200431385T
Other languages
English (en)
Inventor
Bernard Pierre Roques
Nicolas Inguimbert
Marie-Claude Fournie-Zaluski
Pierre Corvol
Catherine Llorens-Cortes
Original Assignee
Edicale Inserm Inst Nat De La
Univ Paris Descartes
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edicale Inserm Inst Nat De La, Univ Paris Descartes, Centre Nat Rech Scient filed Critical Edicale Inserm Inst Nat De La
Publication of SI1651596T1 publication Critical patent/SI1651596T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/66Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/32Esters thereof
SI200431385T 2003-08-06 2004-08-06 Novi derivati ditiobis aminobutan sulfonatov in sestavki ki jih vsebujejo SI1651596T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0309700A FR2858617A1 (fr) 2003-08-06 2003-08-06 Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant
EP04786279A EP1651596B1 (fr) 2003-08-06 2004-08-06 Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
PCT/FR2004/002106 WO2005014535A1 (fr) 2003-08-06 2004-08-06 Derives de 4,4’-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant

Publications (1)

Publication Number Publication Date
SI1651596T1 true SI1651596T1 (sl) 2010-06-30

Family

ID=34073059

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431385T SI1651596T1 (sl) 2003-08-06 2004-08-06 Novi derivati ditiobis aminobutan sulfonatov in sestavki ki jih vsebujejo

Country Status (14)

Country Link
US (1) US7582797B2 (sl)
EP (1) EP1651596B1 (sl)
JP (1) JP4718461B2 (sl)
AT (1) ATE455097T1 (sl)
CA (1) CA2533432C (sl)
CY (1) CY1109950T1 (sl)
DE (1) DE602004025119D1 (sl)
DK (1) DK1651596T3 (sl)
ES (1) ES2339354T3 (sl)
FR (1) FR2858617A1 (sl)
PL (1) PL1651596T3 (sl)
PT (1) PT1651596E (sl)
SI (1) SI1651596T1 (sl)
WO (1) WO2005014535A1 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2931151A1 (fr) * 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
WO2010014943A2 (en) * 2008-08-01 2010-02-04 Bioxiness Pharmaceutics, Inc. Methionine analogs and methods of using same
EP2439192A1 (en) * 2010-10-07 2012-04-11 Quantum Genomics Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid)
HUE033403T2 (en) * 2011-12-21 2017-11-28 Quantum Genomics Combination with (3S, 3S ') - 4,4'-disulfandyl-bis (3-aminobutane-1-sulfonic acid) and a second antihypertensive agent
EP2722327A1 (en) 2012-10-22 2014-04-23 Quantum Genomics Crystalline phase of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) with L-lysine
JP2017532348A (ja) * 2014-10-17 2017-11-02 ユニバーシティ オブ フロリダ リサーチ ファウンデーション 新規な小分子抗癌剤
TW202100146A (zh) * 2019-03-11 2021-01-01 法商量子基因科技有限公司 用於治療高血壓或心衰竭的化合物及包含其之組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5021134A1 (es) * 1998-05-01 2001-03-27 Abbott Lab Inhibidores beta-aminoacidos substituidos de aminopeptida- sa-2 metionina
US6919307B2 (en) * 2000-11-01 2005-07-19 Praecis Pharmaceuticals, Inc. Therapeutic agents and methods of use thereof for the modulation of angiogenesis
JP2005508841A (ja) * 2001-03-29 2005-04-07 スミスクライン・ビーチャム・コーポレイション 化合物および方法

Also Published As

Publication number Publication date
PL1651596T3 (pl) 2010-08-31
CA2533432A1 (fr) 2005-02-17
US20060205695A1 (en) 2006-09-14
ES2339354T3 (es) 2010-05-19
EP1651596B1 (fr) 2010-01-13
DK1651596T3 (da) 2010-05-10
US7582797B2 (en) 2009-09-01
CA2533432C (fr) 2013-05-21
WO2005014535A1 (fr) 2005-02-17
CY1109950T1 (el) 2014-09-10
FR2858617A1 (fr) 2005-02-11
EP1651596A1 (fr) 2006-05-03
JP2007501204A (ja) 2007-01-25
ATE455097T1 (de) 2010-01-15
PT1651596E (pt) 2010-04-16
DE602004025119D1 (de) 2010-03-04
JP4718461B2 (ja) 2011-07-06

Similar Documents

Publication Publication Date Title
BE2017C018I2 (sl)
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MXPA03010207A (es) Nuevas 4-anilinoquinolin-3-carboxamidas.
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2004004657A3 (en) Hiv integrase inhibitors
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
CY1109950T1 (el) Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
MXPA03010766A (es) Nuevos compuestos y composiciones como inhibicores de las catepsinas.
MXPA04003755A (es) Endoprotesis vasculares.
MY140081A (en) Pharmaceutical formulations of modafinil
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
MXPA04005809A (es) Inhibidores de proteinas quinasas.
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA04003910A (es) Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar.
MXPA04005151A (es) Compuestos terapeuticos.
YU34604A (sh) Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže
TW200503672A (en) 2-aminobenzoyl derivatives
GB0309440D0 (en) Quinolone derivatives
RS20050421A (en) Aminoindazole derivatives and use thereof as kinase inhibitors
TW200603801A (en) Novel dialkoxy-imidazopyridines